Nebenwirkungen · Minjuvi
MINJUVI 200 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10–11
HOS-147420 · Präparat HOS-099656
10 pseudomonal sepsis, pseudomonal skin infection, pseudomonas infection, pulmonary sepsis, pulpitis dental, pyelonephritis, salmonellosis, septic shock, sinusitis, skin infection, soft tissue infection, staphylococcal bacteraemia, staphylococcal infection, tooth abscess, tooth infection, urinary tract infection, urosepsis, vaginal infection, and wound infection. d Includes neutropenia and neutrophil count decreased. e Includes thrombocytopenia and platelet count decreased. f Includes anaemia and haematocrit decreased. g Includes abdominal pain, abdominal discomfort, abdominal pain lower, abdominal pain upper, and gastrointestinal pain. h Includes rash, rash erythematous, rash maculo-papular, rash papular, rash pruritic, rash pustular, rash vesicular, and urticaria. i Includes asthenia, malaise, and fatigue.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-27T10:55:00Z · SHA-256 db2a7a79208ec69a20e38f53f43274347a2acea4998641e0c9491f94bc291602 · Passage 06cda18aa50e1ddd66ef04fe2a6d688818a46a38fb8004f12a535efe1b40d7ff · Zeichen 13420–14288 im Abschnitt